Amgen Ventures - Unicorn Nest

Amgen Ventures

Amgen Ventures

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, San Francisco

About

Amgen Ventures was established in 2004, and is a well known VC. The fund is located in United States, North America. The primary office of this VC is located in San Francisco.

Among the most popular investment industries for the fund are Health Care, Biopharma. However, the fund’s focus is not limited to this, since there are 13 more areas of investment. The average start-up age at the time of investment by this fund is 4-5. Alector, TetraLogic Pharmaceuticals, Senti Biosciences are among the most popular portfolio start-ups of the fund. The country of its foundation and the country of the most frequent investments for the fund coincides - United States. In addition to this location, the fund participated in 4 other locations. The fund has no a preferred number of founders for start-ups that it invests in. If there are 5+ founders in the start-up, the probability of getting the investment is low.

The fund typically invests in rounds with 6-7 participants. Aside from Amgen Ventures, start-ups are often funded by Alta Partners, SV Health Investors, ARCH Venture Partners and 59 other funds. Other VCs who often invest in the same rounds are OVP Venture Partners, HealthCare Ventures, Alta Partners, the total number of co-investors is 73. In subsequent rounds, the fund is usually joined by HealthCare Ventures, Alta Partners, Remeditex Ventures, as well as 43 other investors.

The fund was created by Leroy Hood, Marvin Caruthers. Besides the listed founders, we have found 1 key employee of this fund in our database.

The fund usually participates in 2-6 investment rounds per year. Typical investments for this fund are deals in the range of 10 - 50 millions dollars. The highest number of exits from this fund were in 2014. At the time of investment by Amgen Ventures, a typical start-up valuation would be 100-500 millions dollars. The fund's activity peaked in 2018. In addition, the fund was active in 2019. In real terms, this VC performs 11 percentage points less exits than other funds. Amgen Ventures participates, on average, in 1 percentage points less than the average amount of lead investments in other funds.

Year Founded

2004

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: amgen.com; User name format in descending order of probability: first_initial last, first last, first last_initial, last first_initial, last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]

4-6

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

32.1% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x8.5

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

1.5 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.4 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]

1

Funds Investing in Previous
Rounds

Alta Partners, SV Health Investors, ARCH Venture Partners

Funds Investing in Following
Rounds

HealthCare Ventures, Alta Partners, Remeditex Ventures

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: